CSB adds Carterra LSAXT to its stable of instruments
., the world leader in innovative technologies enabling high-throughput biology, and the announced the addition of the Carterra LSAXT label-free interaction analysis platform to the Center for Structural Biology. 91ºÚÁÏÍø and 91ºÚÁÏÍø Medical Center researchers will be able to discover and characterize large molecules including antibodies.
The LSAXT instrument includes hardware and software features that build upon the capabilities of Carterra’s original and highly successful LSA® instrument while maintaining its impressive throughput and sample efficiency. The LSA platform delivers 100 times the data in 10 percent of the time-to-answer and uses only 1 percent of the sample required by other label-free platforms.
The CSB and Carterra will present an Advancing Research and Discovery Seminar featuring Carterra’s Maria McGresham, Senior Applications Scientist, on October 28 at 3:30pm in 3131 MRB3. A reception will follow the seminar on the MRB3 5th floor atrium. The seminar, Carterra LSAXT: HT-SPR technology for high-resolution drug discovery, will introduce the new platform and explore the use of the technology for high throughput kinetic screening of Fabs from crude periplasmic extracts, characterization of bispecific antibodies and kinome level profiling of a focused small molecule library. to your calendar.
about the new LSA platform and the collaboration between Carterra and the CSB.
Leave a Response
You must be logged in to post a comment